This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX Nordic Congress
Connecting Nordic & Baltic Innovators With Capital
20-21 May 2025Radisson Blu Royal Bergen, Norway
Menu

Sarsia Management

Profile

Sarsia is an early-stage venture capital investor based in Bergen, Norway. We invest in science-based technology companies within blue economy / cleantech and green tech / deep tech and biotechnology/life sciences.

Our strength lays in our technological competence, experience and extensive national and international network of industry and co-investors.

Sarsia Seed Fund I started in 2007 is in the closing phase, after four IPOs, one SPAC out of the total 22 portfolio companies. 1bEUR has been created in shareholder value in the portfolio of Fund I since Sarsia entered as first institutional investor.

Sarsia Seed Fund II has been operational since 2017. The total committed capital is 510 mnok, of which more than half has been called. Fund II is towards the end of its investment phase and has invested in 17 portfolio companies.

Sarsia Fund III commenced operation in 2023, with a total committed capital of 367 mnok, and has entered its investment phase.

We're bringing you

  • IPO Workshop: Approaches to Going Public in the Nordics

    14:50